Trials / Completed
CompletedNCT02078310
Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia
A Randomized, Double-blind, Placebo-controlled, Multiple Oral Dose Escalation for Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Intra-Cellular Therapies, Inc. · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
A Phase 1b/2, Randomized, Double-blind, Placebo-Controlled, Multiple Oral Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients with Dementia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ITI-007 | ITI-007 for Part 1 |
| DRUG | Placebo | ITI-007 for Part 1 |
| DRUG | ITI-007 | ITI-007 for Part 2 |
| DRUG | Placebo | Placebo for Part 2 |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-08-01
- Completion
- 2014-11-01
- First posted
- 2014-03-05
- Last updated
- 2017-11-17
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02078310. Inclusion in this directory is not an endorsement.